Boult Wade Tennant
/Insights

Insights

UK IPO fee rises for patents, trade marks and designs from 1 April 2026

UK IPO to raise patent, trade mark and design fees by 25% from 1 April 2026. Early renewals in some cases can secure current rates. Portfolio planning

Dr Isabel Blanco – Partner announcement

Dr Isabel Blanco in our Spanish trade marks team has been appointed as a Partner of Boult Wade Tennant Spain, S.L.P.

18 March Washington, DC, USA
2026 IPOwners Spring Summit

Partner Susi Fish is attending the 9th annual IPOwners Spring Summit in Washington, DC, USA on 18 March.

Boult’s Trade Mark Team is nominated for two awards at the MIP EMEA Awards 2026

Boult’s trade mark team has been nominated for Trademark Prosecution (Patent & Trademark Attorney Firms).

12 March Leeds
CIPA Yorkshire Regional Meeting 2026

Patent Attorney Olivia Murray is attending the CIPA Yorkshire Regional Meeting 2026 in Leeds on 12 March.

An IP guide to Biosimilars

Overview of EMA-defined biosimilars, EU IP protections and limits including Bolar exemption, SPC manufacturing waiver, skinny labelling and loss of ex

4-5 March 2026 London
WTR Live: Brand Strategy Summit Europe 2026

Partner Gillian Farmer is attending WTR Live: Brand Strategy Summit Europe 2026 on March 4 in London.

A farewell to Aerotel and a welcome to the “intermediate step” – the Supreme Court weighs in on Emotional Perception

The UK Supreme Court has reshaped software patent assessment, moving away from Aerotel toward greater EPO harmonisation and confirming that an ANN is

What constitutes individual character and when online marketplaces can be used as prior art

Two recent invalidity decisions show the risks of relying on online marketplace listings as prior art and demonstrate how design freedom shapes assess

UPC Court fees revision – January 2026

From 1 January 2026, the UPC has increased its court fees by around 33%, with an additional 10% increase for Court of Appeal value-based fees, reflect

EPO vs UPC: Inventive step

The UPC Court of Appeal has clarified its inventive step framework. We compare the UPC’s approach with the EPO’s Problem-Solution analysis, highli

LEGO A/S V. EUIPO – Round 2 – Who is the informed user?

An analysis of T-628/24, where the General Court upheld revocation of Lego’s EU design for a modified plate, questioning how informed users and subt

Boult has been featured in the World Trademark Review’s WTR 1000 for 2026

Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.

What’s in a name? Brooklyn Beckham and celebrity names as trade marks

The Brooklyn Beckham trade mark raises key questions about who controls a celebrity’s own name, the limits of the “own name” defence and the lon

Trends in therapeutic innovation

We reflect on a year of life sciences innovation, highlighting Clarivate’s Drugs to Watch 2025, emerging therapy trends, AI-driven R&D and the evolv

Gürok Turizm ve Madencilik AŞ (‘Gürok’) vs Olav GmbH (‘Olav’) – a question of quantity versus quality?

The General Court overturned an EUIPO revocation, holding that proof of genuine use must be assessed holistically. It rejected excessive evidential bu

12 February 2026 Manchester, UK
IPxNW

Joshua McFarlane is attending IPxNW in Manchester on 12 February 2026. This key networking event brings together IP professionals for insights, connec

19-21 January 2026 Amsterdam
The Pharma & Biotech Patent Litigation Summit Europe 2026

Partners Dr Joanna Peak and Marcus Sims are attending The Pharma & Biotech Patent Litigation Summit Europe on 19-21 January in Amsterdam.

Diverging decisions on inventive step: UPC revokes Sanofi’s Cabazitaxel second medical use patent maintained by EPO

An analysis of how the EPO Boards of Appeal and the UPC Munich Local Division assessed inventive step for Sanofi’s cabazitaxel patent and why they r

Success at the UPC

Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).

MORE

News

image
Dr Isabel Blanco – Partner announcement

Dr Isabel Blanco in our Spanish trade marks team has been appointed as a Partner of Boult Wade Tennant Spain, S.L.P.

image
Boult’s Trade Mark Team is nominated for two awards at the MIP EMEA Awards 2026

Boult’s trade mark team has been nominated for Trademark Prosecution (Patent & Trademark Attorney Firms).

image
UPC Court fees revision – January 2026

From 1 January 2026, the UPC has increased its court fees by around 33%, with an additional 10% increase for Court of Appeal value-based fees, reflecting inflation and operational needs.

image
Boult has been featured in the World Trademark Review’s WTR 1000 for 2026

Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.

News

News

image
Dr Isabel Blanco – Partner announcement

Dr Isabel Blanco in our Spanish trade marks team has been appointed as a Partner of Boult Wade Tennant Spain, S.L.P.

image
Boult’s Trade Mark Team is nominated for two awards at the MIP EMEA Awards 2026

Boult’s trade mark team has been nominated for Trademark Prosecution (Patent & Trademark Attorney Firms).

image
UPC Court fees revision – January 2026

From 1 January 2026, the UPC has increased its court fees by around 33%, with an additional 10% increase for Court of Appeal value-based fees, reflecting inflation and operational needs.

image
Boult has been featured in the World Trademark Review’s WTR 1000 for 2026

Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.

News

Events

18 March
2026 IPOwners Spring Summit

Partner Dr Susi Fish is attending the 2026 IPOwners Spring Summit in Washington, DC on 18 March. The conference is...

12 March
CIPA Yorkshire Regional Meeting 2026

Patent Attorney Olivia Murray is attending the CIPA Yorkshire Regional Meeting 2026 on 12 March in Leeds. The event is...

4-5 March 2026
WTR Live: Brand Strategy Summit Europe 2026

Partner Gillian Farmer is attending WTR Live: Brand Strategy Summit Europe 2026 on 4-5 March. This event unites senior brand...

12 February 2026
IPxNW

IPxNW is a leading networking event for professionals passionate about intellectual property across the North West — bringing together patent...

19-21 January 2026
The Pharma & Biotech Patent Litigation Summit Europe 2026

The Pharma & Biotech Patent Litigation Summit is a major European conference for life-sciences intellectual property professionals, focusing on patent...

1 December
LSPN Europe

LSPN Europe 2025 will focus on end-to-end patent lifecycle management, offering practical strategies for protecting and commercialising innovations in life...

20 November
CIPA Life Sciences Conference

The CIPA Life Sciences Conference is the leading UK event for IP professionals in the pharmaceutical, biotechnology and medical device...

6-10 November
APAA Malaysia 2025

APAA Malaysia 2025 will bring together IP professionals from across the Asia-Pacific region for a week of policy discussions, practical...

3-5 November
BIO-Europe 2025

BIO-Europe 2025 is Europe’s premier annual partnering conference for the biotechnology, pharmaceutical and investment sectors. With over 5,000 attendees from...

30-31 October
12th Lsbc Central European Life Science Investment Conference

The 12th Lsbc Central European Life Science Investment Conference top-level theme is: "The DNA of capital – Cracking the code...

23–25 October 2025
ESI/IPL Joint Fall Conference

Hosted jointly by the ABA Forum on the Entertainment & Sports Industries and the Section of Intellectual Property Law, this...

8–11 October
PTMG Autumn Conference

Organised by the Pharmaceutical Trademarks Group, this conference will bring together trademark professionals to discuss current challenges and opportunities in...

13-15 October
Life Sciences Strategy Summit on IP & Exclusivity

The Life Sciences Strategy Summit on IP & Exclusivity will convene legal and scientific experts to examine critical issues surrounding...